Investor Relations

Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research and regenerative medicine at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. We sell our products to... More >> Recent Releases May 15, 2013 Harvard Bioscience Announces Retirement of CEO and Appointment of Interim CEO May 2, 2013 HBIO Reports First Quarter 2013 Results View all releases » Events & Presentations May 2, 2013 at 11:00 AM ET Q1 2013 Harvard Bioscience, Inc. Earnings Conference Call Feb 28, 2013 at 11:00 AM ET Q4 2012 Harvard Bioscience, Inc. Earnings Conference Call View all events & presentations »

HBIO : NASDAQ 3 Mo.6 Mo.1 Yr. Stock Quote Harvard Bioscience, Inc. Price: 5.18 Change: -0.02 Day High: 5.24 Day Low: 5.15 Volume: 61,200 Delayed at least 20 minutes. Provided by eSignal. Featured Reports 2011 Annual Report

Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.